trending Market Intelligence /marketintelligence/en/news-insights/trending/fmzfwaeeryrz7u4yxqwd7q2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

VTv Therapeutics secures $2.5M investment

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

VTv Therapeutics secures $2.5M investment

High Point, N.C.-based vTv Therapeutics Inc. received a $2.5 million investment from MacAndrews & Forbes Group LLC.

The drug developer exercised its right — part of a July 30 agreement — to have the investor acquire 1,879,699 of its class A common shares at $1.33 each.

VTv Therapeutics discovers, develops and sells orally administered small molecule drug candidates.